IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kpcb XIV Associates, LLC

Q3 2020 Holdings

Filed 2020-10-20 | 1 holdings | $7.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Oyster Point Pharma, Inc.Common Stock69242L106$7.8K367,987100.0%